OLV RESEARCH UNIT
0474.229.139 · rovalta.com · 24/09/2026
ACTIVE
OLV RESEARCH UNIT
Financial year 2022 · closed on 31/12/2022
Net result
-80,7 k €
+17.7% YoY
Gross margin
-57,1 k €
+12.9% YoY
Equity
343,2 k €
-19.0% YoY
Overview
What does OLV RESEARCH UNIT do?
OLV RESEARCH UNIT is a Non-profit organization incorporated in 2001. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Aalst.
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0474.229.139
Incorporation
17/01/2001
Legal form
Non-profit organization
Registered office
Moorselbaan 164
9300 Aalst · FlandreSee on map
9300 Aalst · FlandreSee on map
Latest accounts
31/12/2022
Activities (NACE)
Joint committees (1)
- 330
Signals
Solid equityLow riskGood liquidity
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 16 financial years
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||
| Gross margin | -57,1 k € | +12.9% | -65,5 k € | -159% | -25,3 k € | +54.9% | -56,2 k € | -99.6% | -28,1 k € | +49.4% | -55,7 k € | -377% | -11,7 k € | +75.9% | -48,4 k € | +74.0% | -186,5 k € | -10.1% | -169,4 k € | -268% | -46 k € | -739% | 7,2 k € | +123% | -30,7 k € | -159% | -11,8 k € | -103% | 452,2 k € | +5.5% | 428,4 k € |
| EBITDA | -60 k € | +21.6% | -76,6 k € | -131% | -33,2 k € | +51.0% | -67,8 k € | -116% | -31,4 k € | +48.7% | -61,3 k € | -271% | -16,5 k € | +68.2% | -51,9 k € | +72.6% | -189,6 k € | -5.4% | -179,9 k € | -192% | -61,7 k € | -3635% | 1,7 k € | +104% | -42,2 k € | +31.5% | -61,6 k € | -118% | 348,8 k € | -8.7% | 382,3 k € |
| Operating result | -80,5 k € | +16.5% | -96,4 k € | -92.5% | -50,1 k € | +39.3% | -82,6 k € | -66.4% | -49,6 k € | +37.8% | -79,7 k € | -128% | -34,9 k € | +50.0% | -69,8 k € | +67.2% | -212,9 k € | -5.7% | -201,5 k € | -142% | -83,2 k € | -271% | -22,4 k € | +77.3% | -98,8 k € | +18.1% | -120,6 k € | -142% | 289,1 k € | -10.3% | 322,5 k € |
| Net result | -80,7 k € | +17.7% | -98 k € | -94.5% | -50,4 k € | +39.2% | -82,8 k € | -62.4% | -51 k € | +36.9% | -80,9 k € | -139% | -33,9 k € | +50.0% | -67,8 k € | +66.9% | -205 k € | -3.0% | -199 k € | -143% | -81,8 k € | -412% | -16 k € | +83.4% | -96,4 k € | +10.2% | -107,4 k € | -135% | 307,4 k € | -7.3% | 331,5 k € |
| Balance sheet | |||||||||||||||||||||||||||||||
| Equity | 343,2 k € | -19.0% | 423,8 k € | -18.8% | 521,8 k € | -8.8% | 572,2 k € | -12.6% | 655 k € | -7.2% | 706 k € | -10.3% | 786,9 k € | -4.1% | 820,8 k € | -7.6% | 888,6 k € | -18.7% | 1,1 M € | -15.4% | 1,3 M € | -6.0% | 1,4 M € | -1.1% | 1,4 M € | -6.5% | 1,5 M € | -6.7% | 1,6 M € | +23.9% | 1,3 M € |
| Total assets | 363,3 k € | -18.7% | 447,1 k € | -20.0% | 558,6 k € | -5.2% | 589,3 k € | -10.2% | 656,4 k € | -8.4% | 716,7 k € | -10.1% | 797,5 k € | -4.7% | 837,2 k € | -7.8% | 908,1 k € | -34.0% | 1,4 M € | +4.9% | 1,3 M € | -5.5% | 1,4 M € | -2.4% | 1,4 M € | -5.3% | 1,5 M € | -10.1% | 1,7 M € | +21.7% | 1,4 M € |
| Cash | 9,3 k € | +395% | 1,9 k € | -91.1% | 21,1 k € | +53.3% | 13,8 k € | -55.9% | 31,2 k € | +51.6% | 20,6 k € | -65.9% | 60,3 k € | -26.0% | 81,6 k € | -20.5% | 102,6 k € | -26.2% | 139 k € | +102% | 68,8 k € | +343% | 15,5 k € | -74.5% | 60,8 k € | +122% | 27,4 k € | -83.2% | 163,2 k € | +408% | 32,1 k € |
| Debts | 20,1 k € | -13.4% | 23,2 k € | -36.7% | 36,7 k € | +115% | 17,1 k € | +1144% | 1,4 k € | -83.4% | 8,3 k € | +3.3% | 8 k € | -51.4% | 16,5 k € | -15.8% | 19,6 k € | -93.1% | 282,3 k € | +1356% | 19,4 k € | +40.6% | 13,8 k € | -57.6% | 32,5 k € | +97.7% | 16,5 k € | -78.7% | 77,4 k € | -10.3% | 86,3 k € |
| Other | |||||||||||||||||||||||||||||||
| Workforce | – | – | – | – | – | – | – | – | – | – | 0,2 ETP | – | – | 0,8 ETP | -38.5% | 1,3 ETP | +225% | 0,4 ETP | |||||||||||||
Estimate
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2022 · 5 active · 32 ended
Active mandates
Karl Morias
ActiveKoen Suy
ActiveLuc Foubert
ActiveNathalie De Mey
ActiveStefaan Bouchez
ActiveEnded mandates
Demeyer Ignace
EndedFoubert Luc
EndedKarl Morias
EndedKoen Suy
EndedAt this address
Other companies at this address
| Company | CBE no. |
|---|---|
| 1017.929.183 | |
Algemene Heelkunde AZORG● Active | 1017.519.607 |
| 1022.351.789 | |
Associatie Endocrinologie AZORG● Active | 1019.698.840 |
| 0760.768.525 | |
| 0769.516.143 | |
AZORG● Active | 1005.154.085 |
Azorg-ASZ● Active | 0686.624.891 |
| 0865.982.940 | |
CARDIAC RESEARCH INSTITUTE● Active | 0629.850.791 |
CARDIO INVEST● Active | 1018.122.292 |
| 0470.425.452 | |
Centrale Inning AZORG● Active | 0775.987.330 |
| 0725.796.065 | |
| 0673.662.030 | |
FV Orthopedie-Traumatologie● Active | 0670.549.419 |
Gastro-Enterologie AZORG● Active | 1023.116.012 |
Hartcentrum Aalst● Active | 1013.658.017 |
Levilo Health● Active | 1017.107.752 |
Maatschap Pool Cardio● Active | 0690.860.031 |
Financials
Annual accounts
Full financial information
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 |
| Closing of the financial year | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/08/2023 | 30/09/2022 | 26/08/2021 | 23/10/2020 | 14/10/2019 | 04/12/2018 |
| General meeting | 23/08/2023 | 31/08/2022 | 30/06/2021 | 29/09/2020 | 29/08/2019 | 25/09/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
16 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2022 | 23/08/2023 | 31/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 31/08/2022 | 30/09/2022 | Dutch | |
| Abridged model | 31/12/2020 | 30/06/2021 | 26/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 29/09/2020 | 23/10/2020 | Dutch | |
| Abridged model | 31/12/2018 | 29/08/2019 | 14/10/2019 | Dutch | |
| Abridged model | 31/12/2017 | 25/09/2018 | 04/12/2018 | Dutch | |
| Abridged model | 31/12/2016 | 07/06/2017 | 27/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 01/06/2016 | 13/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 31/07/2015 | 28/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 04/06/2014 | 16/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 05/06/2013 | 05/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 06/06/2012 | 17/07/2012 | Dutch | |
| Abridged model | 31/12/2010 | 01/06/2011 | 30/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 02/06/2010 | 30/08/2010 | Dutch | |
| Abridged model | 31/12/2008 | 03/06/2009 | 31/08/2009 | Dutch | |
| Abridged model | 31/12/2007 | 04/06/2008 | 23/10/2008 | Dutch |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2022 · 5 active · 32 ended
Active mandates
Karl Morias
ActiveKoen Suy
ActiveLuc Foubert
ActiveNathalie De Mey
ActiveStefaan Bouchez
ActiveEnded mandates
Demeyer Ignace
EndedFoubert Luc
EndedKarl Morias
EndedKoen Suy
EndedShareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates12/03/2025ONTSLAGEN - BENOEMINGEN
- Mandates26/04/2019ONTSLAGEN - BENOEMINGEN
- Mandates17/07/2012ONTSLAGEN - BENOEMINGEN
- Mandates14/03/2011ONTSLAGEN - BENOEMINGEN
- Mandates11/10/2006ONTSLAGEN - BENOEMINGEN
- Mandates28/01/2005ONTSLAGEN - BENOEMINGEN
- Mandates15/01/2004ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2022Annual accounts 2022-80,7 k €↑
- 2021Annual accounts 2021-98 k €↓
- 2020Annual accounts 2020-50,4 k €↑
- 2019Annual accounts 2019-82,8 k €↓
- 2018Annual accounts 2018-51 k €↑
- 2017Annual accounts 2017-80,9 k €↓
- 2016Annual accounts 2016-33,9 k €↑
- 2015Annual accounts 2015-67,8 k €↑
- 2014Annual accounts 2014-205 k €↓
- 2013Annual accounts 2013-199 k €↓
- 2012Annual accounts 2012-81,8 k €↓
- 2011Annual accounts 2011-16 k €↑
- 2010Annual accounts 2010-96,4 k €↑
- 2009Annual accounts 2009-107,4 k €↓
- 2008Annual accounts 2008307,4 k €↓
- 2007Annual accounts 2007331,5 k €
- 17/01/2001IncorporationNon-profit organization